MoneyWorks4Me

A slight decline in the revenue of Rs. 9056.10 millions was seen for the September 2022 quarter as against Rs. 9157.70 millions during year-ago period.Net profit for the quarter ended September 2022 increases to Rs. 1935.60  millions from Rs. 1875.60 millions.The company reported a good operating profit of 2790.80 millions compared to 2690.50 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 9056.10 9157.70 -1.11 16350.70 16176.10 1.08 32175.10 29204.70 10.17
Other Income 221.60 150.50 47.24 499.50 467.80 6.78 762.20 1101.90 -30.83
PBIDT 2790.80 2690.50 3.73 4548.00 4325.20 5.15 8320.50 7079.60 17.53
Interest 3.90 3.50 11.43 10.70 11.40 -6.14 19.90 35.30 -43.63
PBDT 2786.90 2687.00 3.72 4537.30 4313.80 5.18 8416.40 5318.30 58.25
Depreciation 163.60 174.30 -6.14 321.80 349.70 -7.98 681.90 786.00 -13.24
PBT 2623.30 2512.70 4.40 4215.50 3964.10 6.34 7734.50 4532.30 70.65
TAX 687.70 637.10 7.94 1123.60 1022.50 9.89 3968.70 1665.40 138.30
Deferred Tax -46.30 -37.80 22.49 -81.00 -72.60 11.57 -105.00 78.70 -233.42
PAT 1935.60 1875.60 3.20 3091.90 2941.60 5.11 3765.80 2866.90 31.35
Equity 1694.10 1694.10 0.00 1694.10 1694.10 0.00 1694.10 1694.10 0.00
PBIDTM(%) 30.82 29.38 4.89 27.82 26.74 4.03 25.86 24.24 6.68
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..